Cabotegravir for the prevention of HIV-1 in women: results from HPTN 084, a phase 3, randomised clinical trial.
In: Lancet, Jg. 399 (2022-05-07), Heft 10337, S. 1779-1789
Online
academicJournal
Zugriff:
Titel: |
Cabotegravir for the prevention of HIV-1 in women: results from HPTN 084, a phase 3, randomised clinical trial.
|
---|---|
Autor/in / Beteiligte Person: | Delany-Moretlwe, Sinead ; Hughes, James P ; Bock, Peter ; Ouma, Samuel Gurrion ; Hunidzarira, Portia ; Kalonji, Dishiki ; Kayange, Noel ; Makhema, Joseph ; Mandima, Patricia ; Mathew, Carrie ; Spooner, Elizabeth ; Mpendo, Juliet ; Mukwekwerere, Pamela ; Mgodi, Nyaradzo ; Ntege, Patricia Nahirya ; Nair, Gonasagrie ; Nakabiito, Clemensia ; Nuwagaba-Biribonwoha, Harriet ; Panchia, Ravindre ; Singh, Nishanta |
Link: | |
Zeitschrift: | Lancet, Jg. 399 (2022-05-07), Heft 10337, S. 1779-1789 |
Veröffentlichung: | 2022 |
Medientyp: | academicJournal |
ISSN: | 0140-6736 (print) |
DOI: | 10.1016/S0140-6736(22)00538-4 |
Sonstiges: |
|